Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C

نویسندگان

چکیده

Australia's recent investment in, and optimism about, direct-acting antivirals to treat hepatitis C brings with it the promise of new drug futures, including possibility a post-hepatitis world revolution in lives people affected by disease. But is situation more complicated than we might assume? What expectations are being produced about post-cure lives? And what overlooked along way? We argue that policy, practice research can instantiate problematic orientation towards medicine ‘the future’ explore ways moving beyond these orientations. The essay then proceeds into two main stages. First, combining critiques from existing preliminary insights study on ‘post-cure’ lives, outline some key logics regarding cure post-cure, explain why such problematic. against assumption availability medical will alone reverse entrenched social, political structural dynamics drive infections limit service access. To do so, note, overlook net meanings power relations co-constitute injecting use render those associated them marginalised disenfranchised. Such erases legacy laws policies devised pre-cure world, their role generating limiting being. Second, introduce ideas field articulate vision for call ‘futurology’ C, designed counter assumptions take us temporal logics. Our futurology inspired work Cuevas-Hewitt (2011) ‘futurology present’. Cuevas-Hewitt's approach discards linear temporalities, reform, instead pays attention multiplicities becoming perpetual present. Taking up Cuevas-Hewitt, our own sketches C’. This set practices thinking, researching, writing otherwise engaging characterised not an imagined, singular future look like, or treatment as revolutionary, but calls multiple ‘perpetual presents’ already us, aims foment hope change.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hepatitis C cure with antiviral therapy--benefits beyond the liver.

Liver disease is the major complication of chronic HCV infection. However, extrahepatic complications are common (50-75%), including mixed cryoglobulinaemia and B-cell lymphomas. Given that chronic hepatitis C has become curable using expensive oral direct-acting antivirals (DAAs), it seems worth revisiting the whole spectrum and burden of disease in HCV carriers.Herein, we update the most clin...

متن کامل

Cure of hepatitis C.

Since the discovery of the hepatitis C virus in 1989, many epidemiological data have been acquired, especially in Europe. Treatments have showed substantial improvement over the past 25 years and have taken a great leap forward with the development of the direct antiviral agents (DAAs). However, the burden of hepatitis C remains important in Europe with more than 5 million individuals living wi...

متن کامل

a new approach to credibility premium for zero-inflated poisson models for panel data

هدف اصلی از این تحقیق به دست آوردن و مقایسه حق بیمه باورمندی در مدل های شمارشی گزارش نشده برای داده های طولی می باشد. در این تحقیق حق بیمه های پبش گویی بر اساس توابع ضرر مربع خطا و نمایی محاسبه شده و با هم مقایسه می شود. تمایل به گرفتن پاداش و جایزه یکی از دلایل مهم برای گزارش ندادن تصادفات می باشد و افراد برای استفاده از تخفیف اغلب از گزارش تصادفات با هزینه پائین خودداری می کنند، در این تحقیق ...

15 صفحه اول

“Sell an Ox” - The Price of Cure for Hepatitis C in Two Countries

Chronic hepatitis C virus (HCV) infection, associated with severe liver disease and cancer, affects 70 million people worldwide. New treatments with direct-acting-antivirals offer cure for about 95% of affected individuals; however, treatment costs may be prohibitive in both the poorest and richest nations. Opting for cure may require sacrificing essential household ass...

متن کامل

Pioneering a Global Cure for Chronic Hepatitis C Virus Infection

This year's Lasker∼Debakey Clinical Medical Research Award honors Ralf Bartenschlager, Charles Rice, and Michael Sofia, pioneers in the development of curative and safe therapies for the 170 million people with hepatitis C virus infection.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Drug Policy

سال: 2021

ISSN: ['1873-4758', '0955-3959']

DOI: https://doi.org/10.1016/j.drugpo.2020.103042